Announcements Trials
Browse Landscape

Phase

Phase 1 28Phase 1/2 13Phase 2 5Phase EARLY_PHASE1 1

Status

Unknown 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 12Plasma cell 8Other hematologic neoplasm 5Other solid neoplasm 4Gynecologic 3Head & Neck 2Gastrointestinal 2Tumor-Agnostic 1Thoracic 1Genitourinary 1Dermatologic 1CNS 1

Conditions

Metastatic Castration-resistant Prostate Cancer 1

Interventions

Magnetic Resonance Spectroscopy 13gallium 68 PSMA-11 8Fluorodeoxyglucose F18 5Specimen Handling 4Positron Emission Tomography Computed Tomography 42-(3-(1-carboxy-5-((6-fluoropyridine-3-carbonyl)amino)pentyl)ureido)pentanedioic acid 4enzalutamide 3Nivolumab 3Ipilimumab 3Interleukin-2 3Biopsy 368Ga-DKFZ-PSMA-11 3pembrolizumab 2pazopanib 2lenvatinib 2bicalutamide 2atezolizumab 2aldesleukin 2acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 2X-Rays 2Standard of Care 2Radiation 2Positron-Emission Tomography 2Paclitaxel 2Oncolytic Virotherapy 2Nephrectomy 2Metformin 2Metastasectomy 2Immunoglobulin G 2Hydroxychloroquine 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase EARLY_PHASE1 × fludarabine × Genitourinary × Clear all
NCT03692663 2022-08-01

Study of Anti-PSMA CAR NK Cell (TABP EIC) in Metastatic Castration-Resistant Prostate Cancer

Allife Medical Science and Technology Co., Ltd.

Phase EARLY_PHASE1 Unknown
9 enrolled
Genitourinary

Metastatic Castration-resistant Prostate Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡